Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5732a29c0335e2d9a502b24d5ff67 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_439abb5fa3265a73407b3e978be031fe |
publicationDate |
2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11090261-B2 |
titleOfInvention |
Aqueous ophthalmic solutions of phentolamine and medical uses thereof |
abstract |
The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11566005-B2 |
priorityDate |
2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |